India's Aarti Drugs surges as U.S. FDA lifts import restrictions

Aarti Drugs

14/02/2025 10:13

** Shares of Aarti Drugs  ADRG.NS  jump 13% to 433 rupees,
in a broader weak market
    ** US FDA lifts import restrictions imposed following
inspection at co's active pharmaceutical ingredient (API)
manufacturing facility   
    ** Following the order, ADRG can now export its API products
to the US 
    ** Nifty Pharma Index  .NIPHARM  is down 3% on Trump tariff
woes; ADRG is not part of the index   
    ** ADRG trading vols at 3.5x their 30-day avg     
    ** Stock is down around 13% YTD 

 (Reporitng by Nishit Navin)
 ((nishit.navin@thomsonreuters.com;))